ExodusPoint Capital Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,437
| Closed | -$254K | – | 1879 |
|
|
2025
Q1 | $254K | Buy |
+28,437
| New | +$254K | ﹤0.01% | 1203 |
|
|
2024
Q4 | – | Sell |
-38,018
| Closed | -$306K | – | 1921 |
|
|
2024
Q3 | $306K | Sell |
38,018
-42,937
| -53% | -$346K | ﹤0.01% | 1251 |
|
|
2024
Q2 | $686K | Buy |
80,955
+200
| +0.2% | +$1.7K | ﹤0.01% | 1009 |
|
|
2024
Q1 | $724K | Buy |
+80,755
| New | +$724K | 0.01% | 934 |
|
|
2023
Q4 | – | Sell |
-117,318
| Closed | -$1.01M | – | 1961 |
|
|
2023
Q3 | $1.01M | Buy |
117,318
+13,637
| +13% | +$118K | 0.01% | 927 |
|
|
2023
Q2 | $1.07M | Buy |
+103,681
| New | +$1.07M | 0.01% | 989 |
|
|
2022
Q2 | – | Sell |
-53,850
| Closed | -$515K | – | 2366 |
|
|
2022
Q1 | $515K | Buy |
+53,850
| New | +$515K | 0.01% | 1429 |
|
|
2021
Q4 | – | Sell |
-14,791
| Closed | -$109K | – | 2518 |
|
|
2021
Q3 | $109K | Sell |
14,791
-76,073
| -84% | -$561K | ﹤0.01% | 1841 |
|
|
2021
Q2 | $1.32M | Buy |
+90,864
| New | +$1.32M | 0.01% | 801 |
|
|
2020
Q4 | – | Sell |
-18,472
| Closed | -$273K | – | 2276 |
|
|
2020
Q3 | $273K | Sell |
18,472
-12,933
| -41% | -$191K | 0.01% | 1269 |
|
|
2020
Q2 | $659K | Buy |
+31,405
| New | +$659K | 0.02% | 921 |
|